Pages that link to "Q102335468"
Jump to navigation
Jump to search
The following pages link to Gil I Wolfe (Q102335468):
Displaying 50 items.
- International consensus guidance for management of myasthenia gravis: Executive summary (Q26746047) (← links)
- A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy (Q28272415) (← links)
- International clinimetric evaluation of the MG-QOL15, resulting in slight revision and subsequent validation of the MG-QOL15r (Q30276744) (← links)
- The MG-QOL15 for following the health-related quality of life of patients with myasthenia gravis (Q30452295) (← links)
- Randomized Trial of Thymectomy in Myasthenia Gravis (Q30833195) (← links)
- Static magnetic field therapy for symptomatic diabetic neuropathy: a randomized, double-blind, placebo-controlled trial (Q33846024) (← links)
- Consensus treatment recommendations for late-onset Pompe disease (Q34634354) (← links)
- Implementing clinical trials on an international platform: challenges and perspectives (Q35663409) (← links)
- Painful peripheral neuropathy and its nonsurgical treatment (Q35819852) (← links)
- Biomarker development for myasthenia gravis (Q36515375) (← links)
- Antibody testing in peripheral neuropathies (Q36745946) (← links)
- A genome-wide association study of myasthenia gravis (Q36869250) (← links)
- Reversible nitrous oxide-induced myeloneuropathy with pernicious anemia: case report and literature review (Q36876681) (← links)
- The MGTX experience: challenges in planning and executing an international, multicenter clinical trial (Q37124575) (← links)
- Treatment review and update for myasthenia gravis (Q37349522) (← links)
- Fibrocartilaginous embolism: a comprehensive review of an under-studied cause of spinal cord infarction and proposed diagnostic criteria (Q37354114) (← links)
- Muscle-specific receptor tyrosine kinase antibody-positive and seronegative myasthenia gravis (Q37435603) (← links)
- Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience (Q37625980) (← links)
- Therapy update in nerve, neuromuscular junction and myopathic disorders (Q37776125) (← links)
- Idiopathic neuropathy: new paradigms, new promise. (Q38006763) (← links)
- Recommendations for myasthenia gravis clinical trials (Q38009753) (← links)
- Asymptomatic/pauci-symptomatic creatine kinase elevations (hyperckemia). (Q38102654) (← links)
- Treatment of painful peripheral neuropathy (Q38104039) (← links)
- Treatment-refractory myasthenia gravis (Q38215715) (← links)
- Low-Dose Medication and Long-Term Outcome in Myasthenia Gravis (Q39012659) (← links)
- Treatment of painful peripheral neuropathy. (Q39400574) (← links)
- Cerebral paragonimiasis: an unusual manifestation of a rare parasitic infection (Q41565279) (← links)
- North America and South America (NA-SA) neuropathy project (Q42272505) (← links)
- Adult polyglucosan body disease associated with lewy bodies and tremor (Q42441512) (← links)
- Isolated Neck Extensor Myopathy: Is it Responsive to Immunotherapy? (Q42920958) (← links)
- Two steps forward, one step back: mycophenolate mofetil treatment for myasthenia gravis in the United States (Q44092529) (← links)
- Cholinergic autonomic dysfunction in veterans with Gulf War illness: confirmation in a population-based sample (Q44111790) (← links)
- Challenges in the identification of cobalamin-deficiency polyneuropathy (Q44585438) (← links)
- Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridine (Q45023480) (← links)
- Painful Peripheral Neuropathy (Q45306771) (← links)
- Blunted circadian variation in autonomic regulation of sinus node function in veterans with Gulf War syndrome (Q45333372) (← links)
- Comparative clinical outcomes of thymectomy for myasthenia gravis performed by extended transsternal and minimally invasive approaches (Q46151963) (← links)
- Von hippel-lindau disease associated with thymoma and myasthenia gravis (Q46200430) (← links)
- Comparison of outcome measures from a trial of mycophenolate mofetil in myasthenia gravis (Q46298755) (← links)
- Status of the thymectomy trial for nonthymomatous myasthenia gravis patients receiving prednisone (Q46528757) (← links)
- Clinical phenotype of muscle-specific tyrosine kinase-antibody-positive myasthenia gravis (Q46528822) (← links)
- Repetitive nerve stimulation of facial muscles in MuSK antibody-positive myasthenia gravis (Q46878760) (← links)
- Alfred Jaretzki III, MD. (Q48070351) (← links)
- Posterior reversible encephalopathy syndrome secondary to blood transfusion (Q48398808) (← links)
- Developing treatment guidelines for myasthenia gravis (Q48510346) (← links)
- Learning from the past: reflections on recently completed myasthenia gravis trials (Q48621943) (← links)
- Author response: International consensus guidance for management of myasthenia gravis: Executive summary (Q48705258) (← links)
- Start high, then go low: An effective strategy in the treatment of myasthenia gravis (Q48805377) (← links)
- Efficacy of prednisone for the treatment of ocular myasthenia (EPITOME): A randomized, controlled trial (Q50954321) (← links)
- Myasthenia gravis (Q51304125) (← links)